Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Increasing Incidence of Pancreatic Cancer Leading to a $6.85
View:
Post by whytestocks on Mar 05, 2024 12:00pm

Increasing Incidence of Pancreatic Cancer Leading to a $6.85

JUST IN: $ONCY Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New TreatmentsPALM BEACH, Fla., March 05, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Pancreatic cancer is one of the leading causes of cancer death globally. The increasing incidence of this cancer across the U.S. and other parts of the world is one of the factors driving the need fo...ONCY - Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Treatments
Comment by askretka on Mar 05, 2024 10:44pm
I know we all know by now that the USA Newsgroup thing is a paid promotion by ONC, but other stuff I've come across projects 10 Billion by 2035 for Pancreatic Cancer   So 6.85 Billion market is probably a pretty good number for 2029. https://www.researchnester.com/reports/pancreatic-adenocarcinoma-treatment-market/3373 Cheers!!!!!!!
Comment by Noteable on Mar 06, 2024 11:44am
US$6.5 Billion by 2029 growing to US$36 Billion by 2036 ... with FDA market exclusivity for a biological receiving 13 years of exclusivity from the date of regulatory approval.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities